**Question:** All are useful for management of severe Clostridium difficile treatment except:

A. Metronidazole
B. Vancomycin
C. Sevelamer
D. Doxycycline

**Core Concept:**
Clostridium difficile is a Gram-positive, spore-forming bacterium that can cause antibiotic-associated diarrhea, colitis, and even severe pseudomembranous colitis in susceptible individuals, particularly those with compromised gastrointestinal flora. Treatment options include metronidazole, vancomycin, and doxycycline, while sevelamer is an oral phosphorus-binding agent used in the management of hyperphosphatemia in patients with chronic kidney disease.

**Why the Correct Answer is Right:**
Sevelamer is not effective in treating Clostridium difficile infections because it is a phosphate binder and not an antimicrobial agent. Its primary function is to reduce serum phosphorus levels in patients with chronic kidney disease.

**Why Each Wrong Option is Incorrect:**
A. Metronidazole: A nitroimidazole antibiotic used against anaerobic Gram-negative bacteria, including Clostridium difficile.
B. Vancomycin: A glycopeptide antibiotic effective against Gram-positive bacteria, including Clostridium difficile.
C. Doxycycline: A tetracycline antibiotic with broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including Clostridium difficile.

**Clinical Pearl:**
When treating Clostridium difficile infections, it is essential to consider the appropriate antibiotic therapy based on the specific pathogen involved. Selection of antibiotics should be guided by their antimicrobial spectrum, particularly targeting Gram-positive and anaerobic bacteria like Clostridium difficile. This ensures effective treatment while minimizing the risk of antibiotic resistance development.